According to the FDA, Onglyza consumers are exposed to the risk of getting congestive heart failure. It was decided that Onglyza update their labeling with clear warnings regarding the potentiality of developing heart failure from the latest FDA advisory committee meeting that was held. Before, this warning wasn’t there in the drug’s labels.
In the event, you or anybody you know has taken Onglyza and later experienced heart failure as a result, or somebody close to you died, you may have legal grounds to file a San Diego Onglyza lawsuit. You should know that AstraZeneca is a big company with a team of attorneys that represent its interests when faced with such lawsuits.
Contact Dalimonte Rueb Stoller to get a free case evaluation with our San Diego mass tort lawyers and learn more regarding your rights.
Table of Contents
How And Why Is Onglyza Associated With Heart Failure?
In America, cardiovascular disease is among the significant health issues that result in the deaths of many Americans. According to the CDC, there are about 610,000 fatalities linked to heart disease each year. Doing the math, that is 1 in every 4 deaths in America annually.
For individuals with type 2 diabetes and are taking Onglyza, the connection between the medication and their health issues is astonishing. The FDA began an investigation to learn more about the drug and its association with increased risk of heart failure; this is after growing concerns throughout America. The investigation uncovered troublesome issues with the usage of Onglyza and Kombiglyze XR and resulted in additional warnings of possibly getting heart failure.
Is There A Link Between Onglyza And Pancreatic Cancer?
Onglyza triggers the pancreas to produce more insulin. That’s why it has been linked to increased risk of users contracting pancreatic cancer and pancreatitis.
A research study conducted in 2013, focusing on how DPP-4 inhibitors affect the pancreas discovered that patients with type 2 diabetes and were taking Onglyza were more likely to have an enlarged pancreas. They also face the risk of precancerous cellular changes occurring in their pancreas, which suggests that contracting pancreatic cancer is extremely high.
In March of 2013, the FDA issued another drug safety notice stating that after examining findings from a study, individuals using incretin mimetic for treating their type 2 diabetes are more likely to experience precancerous cellular changes and pancreatitis. Other drugs categorized as incretin mimetics include Januvia, Nesina, Byetta, and Onglyza.
A study conducted later in 2014 on a major clinical trial on Onglyza by researchers; it was concluded that there was no sign of pancreatitis or pancreatic cancer.
Is Onglyza Linked To Thyroid Cancer?
Victoza is an incretin mimetic that shares some properties with Onglyza. When the drug was used on rodents in ‘clinically relevant’ doses, it was found to cause acute pancreatitis and malignant thyroid cancer. In June of 2011, the FDA released a safety warning saying there was an increased risk of developing thyroid cancer from the usage of Victoza. What’s more, the FDA has gotten numerous reports from individuals diagnosed with thyroid cancer after taking prescribed incretin mimetics like Januvia (sitagliptin) and Byetta (exenatide).
Has There Been A Recall Of Onglyza?
There has been no recall announcement as of yet, and it’s highly unlikely that one will be issued in the foreseeable future. The recalls seem unlikely, yet the reality of cancers, heart failure, and other fatal health problems cannot be concealed or overlooked. Vioxx medication was recalled because of causing heart attacks and strokes, alongside other cardiovascular concerns. The same case applies for Onglyza and other related incretin mimetics that increase the likelihood of heart failure. Regardless of the health concerns, the only measures taken for medications like these with dangerous side effects include additional safety warnings on the product labels.
Are There Any Class Action Lawsuits Involving Onglyza That Are Ongoing?
Lawsuits involving drug injury are seldom filed as ‘class action’ where a few plaintiffs will act as representatives to others who’ve filed cases against a manufacturer or drug company. You will have to file such an issue individually.
The U.S Judicial Panel on Multidistrict Litigation in January of 2018 mandated the ‘consolidation’ of pre-existing suits filed against Onglyza and Kombiglyze in the Kentucky U.S District Court for the Eastern District. By May of 2018, there were about 100 of these claims forming consolidated litigation referred to as the MDL 2809. There are other suits still pending in the California State Court.
Can You File An Onglyza Lawsuit Even If It Hasn’t Been Recalled?
The Food and Drug Administration panel suggests that clear warnings be included on the labels indicating the increased risk of suffering heart failure. However, this has confused people about why the warnings were never included in the first place when it was brought to the market ten years ago.
With this being the current situation, it implies that the majority of persons who took Onglyza in the past ten years were oblivious of the health risk. Chances are they may have suffered severe side effects without knowing the underlying cause.
And as per government regulations in San Diego, CA, patients that consumed Onglyza and subsequently suffered heart failure can pursue reimbursement since the pharmaceutical organizations producing the drug failed to offer the public with sufficient safety warnings regarding such an outcome occurring.
Get Assistance With Your San Diego Onglyza Lawsuit
If a loved one or you has taken Onglyza and experienced heart failure, been hospitalized, or a family member has died because of using the drug, the committed class action lawyers at Dalimonte Rueb Stoller are on hand to offer assistance. We have been legal representatives to many people across the U.S., So we have a deeper understanding of what is expected of pharmaceutical companies like AstraZeneca and Bristol Myers Squibb. By law, they have to make sure that patients and doctors are well aware of the potential risks associated with the usage of their drugs. Not doing this means that manufacturers are responsible for damages that individuals suffer from using their medications.
Here at Dalimonte Rueb Stoller law offices, we have handled cases linked to Onglyza and are fully aware of its pitfalls. Therefore, if you want to confront the manufacturers of Onglyza and actually win, we are your best shot at it. Reach out to our San Diego class-action law firm now at (833) 44-DRLAW to get a case assessment and consultation without charge and find out more about your case.